List of Veeva Oncology Link Customers
Pleasanton, 94588, CA,
United States
Since 2010, our global team of researchers has been studying Veeva Oncology Link customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veeva Oncology Link for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veeva Oncology Link for Analytics and BI include: Sanofi Genzyme, a United States based Life Sciences organisation with 4750 employees and revenues of $7.82 billion, Astellas Pharma US, a United States based Life Sciences organisation with 3000 employees and revenues of $700.0 million, Oncopeptides, Inc., a United States based Life Sciences organisation with 88 employees and revenues of $7.0 million and many others.
Contact us if you need a completed and verified list of companies using Veeva Oncology Link, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veeva Oncology Link customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Astellas Pharma US | Life Sciences | 3000 | $700M | United States | Veeva Systems | Veeva Oncology Link | Analytics and BI | 2019 | n/a |
In 2019, Astellas Pharma US implemented Veeva Oncology Link, a Veeva Systems application in the Analytics and BI category, to centralize identification and engagement of oncology scientific experts and support launch readiness. The deployment focused on using Veeva Oncology Link to strengthen relationships with oncology leaders while maintaining GDPR compliance for expert interactions.
The implementation configured analytics-driven expert identification and engagement tracking capabilities, including expert profiling, segmentation, and engagement analytics to surface high-value scientific experts for launch planning. Veeva Oncology Link was used to instrument dashboards and workflows that align medical affairs and commercial engagement efforts, and to standardize outreach records and consent metadata required for compliant engagement.
Governance centered on consent management and data privacy controls to ensure GDPR-compliant expert interactions, with process changes to capture and store consent status alongside engagement activities. Operational scope emphasized oncology medical and commercial functions responsible for launch strategy, and the configuration supported repeatable engagement workflows to enable coordinated scientific expert outreach and relationship strengthening.
|
 |
Oncopeptides, Inc. | Life Sciences | 88 | $7M | United States | Veeva Systems | Veeva Oncology Link | Analytics and BI | 2020 | n/a |
In 2020, Oncopeptides, Inc. implemented Veeva Oncology Link to centralize oncology-specific intelligence for its commercial organization. Veeva Oncology Link is used as an Analytics and BI application to deliver curated intelligence on people, institutions, and developments across the oncology healthcare community, supporting field engagement and strategic sales analytics.
The deployment consolidated clinician and institutional profiles, research and clinical development signals, and outreach intelligence into a single access layer for field teams and the sales analytics function. Configuration emphasized data access and role-based delivery for field users, with sales analytics responsible for operational oversight and content curation. Oncopeptides, Inc. Veeva Oncology Link Analytics and BI relationships focus on enabling field engagement workflows and supporting sales analytics reporting, with users reporting that the solution provides intelligence on people, institutions, and developments all in one place.
|
 |
Sanofi Genzyme | Life Sciences | 4750 | $7.8B | United States | Veeva Systems | Veeva Oncology Link | Analytics and BI | 2017 | n/a |
In 2017 Sanofi Genzyme implemented Veeva Oncology Link as an Analytics and BI application to support Medical Affairs operations and field CRM workflows. The Business Process Owner for Veeva sat in the Medical Affairs Operations Team and was responsible for managing the field CRM environment that included Veeva and Salesforce, establishing operational ownership for ongoing configuration and reporting needs.
Veeva Oncology Link was configured to support user profile updates, territory alignments, loading of Surveys and Field Coaching Reports, and the development of operational reports. The team produced business and functional specifications for customizations after analyzing existing Validation Rules, Triggers and Page Layouts, aligning configuration changes to documented requirements for the Veeva Oncology Link environment.
The implementation involved active collaboration with internal and external support teams and coordination with IT and QA for release management, including facilitating user acceptance testing in HP ALM prior to production deployment. The deployment covered Medical Affairs and field force users across multiple therapeutic areas, and included training and enablement through demo sessions delivered at an off-site Veeva Oncology Summit.
Governance and process changes emphasized streamlining the enhancement request lifecycle and improving issue visibility, with prioritized review meetings to negotiate scope across therapeutic areas and regular progress reporting to Senior Management and Operations Directors. The team also reworked the MIR process by identifying pain points, evaluating solution options, and coordinating delivery and validation through IT and QA.
|
Buyer Intent: Companies Evaluating Veeva Oncology Link
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||